![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2025
Gutmair, Katja 
ORCID: https://orcid.org/0009-0002-3948-6186; Villa, Diego ORCID: https://orcid.org/0000-0002-4625-3009; Cunningham, Nicholas; Silkenstedt, Elisabeth ORCID: https://orcid.org/0000-0003-2676-0860; Rimsza, Lisa; Ramsower, Colleen ORCID: https://orcid.org/0000-0002-4991-7712; Scott, David W. ORCID: https://orcid.org/0000-0002-0435-5947; Gerrie, Alina S. ORCID: https://orcid.org/0000-0003-4727-1425; Kluin-Nelemans, Hanneke C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2025):
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.
In: Blood Advances, Bd. 9, Nr. 9: S. 2302-2306
[PDF, 666kB]
ORCID: https://orcid.org/0009-0002-3948-6186; Villa, Diego ORCID: https://orcid.org/0000-0002-4625-3009; Cunningham, Nicholas; Silkenstedt, Elisabeth ORCID: https://orcid.org/0000-0003-2676-0860; Rimsza, Lisa; Ramsower, Colleen ORCID: https://orcid.org/0000-0002-4991-7712; Scott, David W. ORCID: https://orcid.org/0000-0002-0435-5947; Gerrie, Alina S. ORCID: https://orcid.org/0000-0003-4727-1425; Kluin-Nelemans, Hanneke C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2025):
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.
In: Blood Advances, Bd. 9, Nr. 9: S. 2302-2306
[PDF, 666kB]
2022
Villa, Diego; Hoster, Eva; Hermine, Olivier; Klapper, Wolfram; Szymczyk, Michal; Bosly, Andre; Unterhalt, Michael; Rimsza, Lisa M.; Ramsower, Colleen A.; Freeman, Ciara L.; Scott, David W.; Gerrie, Alina S.; Savage, Kerry J.; Sehn, Laurie H. und Dreyling, Martin
(2022):
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
In: Blood Advances, Bd. 6, Nr. 18: S. 5285-5294